Cargando…

The Clinical Landscape of Circulating Tumor DNA in Gastrointestinal Malignancies

Technologies for genomic analyses have revealed more details in cancer biology and have changed standard treatments for cancer, including the introduction of targeted gene-specific therapy. Currently, liquid biopsies are increasingly being utilized in clinical trials and research settings to analyze...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sawada, Kentaro, Kotani, Daisuke, Bando, Hideaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054927/ https://www.ncbi.nlm.nih.gov/pubmed/30062088 http://dx.doi.org/10.3389/fonc.2018.00263

Ejemplares similares

The Use of Circulating Tumor DNA for Prognosis of Gastrointestinal Cancers
por: Saluja, Hariti, et al.
Publicado: (2018)

A Review of Circulating Tumor DNA in Hepatobiliary Malignancies
por: Mody, Kabir, et al.
Publicado: (2018)

The Mutational Landscape of Pancreatic and Liver Cancers, as Represented by Circulating Tumor DNA
por: Rice, Alistair, et al.
Publicado: (2019)

Characterizing the Genomic Landscape of Brain Glioma With Circulating Tumor DNA From Tumor In Situ Fluid
por: Sheng, Zhiyuan, et al.
Publicado: (2021)

Clinical applications of circulating tumor-derived DNA in the management of gastrointestinal cancers – current evidence and future directions
por: Lam, Rachel C. T., et al.
Publicado: (2022)

Role of Circulating Tumor DNA in Gastrointestinal Cancers: Update From Abstracts and Sessions at ASCO 2018
por: Shahjehan, Faisal, et al.
Publicado: (2019)

Circulating tumor DNA for diagnosis, prognosis and treatment of gastrointestinal malignancies
por: Kirchweger, Patrick, et al.
Publicado: (2022)

Circulating Tumor DNA Mutations in Progressive Gastrointestinal Stromal Tumors Identify Biomarkers of Treatment Resistance and Uncover Potential Therapeutic Strategies
por: Ko, Tun Kiat, et al.
Publicado: (2022)

Clinical Utility of Circulating Tumor DNA in Advanced Rare Cancers
por: Okuma, Hitomi Sumiyoshi, et al.
Publicado: (2021)

Circulating Tumor DNA is Unreliable to Detect Somatic Gene Alterations in Gastrointestinal Peritoneal Carcinomatosis
por: Sullivan, Brittany G., et al.
Publicado: (2022)

Circulating Tumor Cells in Gastrointestinal Cancers: Current Status and Future Perspectives
por: Yang, Chaogang, et al.
Publicado: (2019)

The Landscape of Actionable Genomic Alterations by Next-Generation Sequencing in Tumor Tissue Versus Circulating Tumor DNA in Chinese Patients With Non-Small Cell Lung Cancer
por: Cai, Jun, et al.
Publicado: (2022)

Editorial: The Evolving Landscape, Clinical Implications, and Future Perspective of Biomarkers in Gastrointestinal Cancers
por: Tsai, Hsiang-Lin, et al.
Publicado: (2022)

Circulating Tumor Cells in Genitourinary Malignancies: An Evolving Path to Precision Medicine
por: Hugen, Cory M., et al.
Publicado: (2017)

CIRCULATE‐Japan: Circulating tumor DNA–guided adaptive platform trials to refine adjuvant therapy for colorectal cancer
por: Taniguchi, Hiroya, et al.
Publicado: (2021)

Circulating Tumor Cells in Gastrointestinal Malignancies: Current Techniques and Clinical Implications
por: Lurje, Georg, et al.
Publicado: (2010)

Neutrophil-Lymphocyte Ratio and Circulating Tumor Cells Counts Predict Prognosis in Gastrointestinal Cancer Patients
por: Qian, Chengcheng, et al.
Publicado: (2021)

Molecular landscape and clinical significance of exon 11 mutations in KIT gene among patients with gastrointestinal stromal tumor: a retrospective exploratory study
por: Zhao, Ruihua, et al.
Publicado: (2023)

The Potential Clinical Utility of Circulating Tumor DNA in Esophageal Adenocarcinoma: From Early Detection to Therapy
por: Kosovec, Juliann E., et al.
Publicado: (2018)

Circulating tumor DNA – A potential aid in the management of chordomas
por: Frederico, Stephen C., et al.
Publicado: (2022)

Towards clinical implementation of circulating tumor DNA in metastatic prostate cancer: Opportunities for integration and pitfalls to interpretation
por: Kwan, Edmond M., et al.
Publicado: (2022)

Malignancy risk of gastrointestinal stromal tumors evaluated with noninvasive radiomics: A multi-center study
por: Wang, Yun, et al.
Publicado: (2022)

Landscape Profiling Analysis of DPP4 in Malignancies: Therapeutic Implication for Tumor Patients With Coronavirus Disease 2019
por: Shu, Lingling, et al.
Publicado: (2021)

Clinical significance of the mutational landscape and fragmentation of circulating tumor DNA in renal cell carcinoma
por: Yamamoto, Yoshiyuki, et al.
Publicado: (2019)

A Targeted Gene Panel for Circulating Tumor DNA Sequencing in Neuroblastoma
por: Cimmino, Flora, et al.
Publicado: (2020)

An Improved Detection of Circulating Tumor DNA in Extracellular Vesicles-Depleted Plasma
por: Sun, Li, et al.
Publicado: (2021)

DNA methylation regulators-related molecular patterns and tumor immune landscape in hepatocellular carcinoma
por: Song, Dingli, et al.
Publicado: (2022)

Circulating Tumor DNA Characteristics Based on Next Generation Sequencing and Its Correlation With Clinical Parameters in Patients With Lymphoma
por: Wu, Xiao-Bo, et al.
Publicado: (2022)

Tumor genomic profiling and personalized tracking of circulating tumor DNA in Vietnamese colorectal cancer patients
por: Nguyen, Huu Thinh, et al.
Publicado: (2022)

Editorial: Tailoring immunotherapy in gastrointestinal cancer: the role of circulating factors
por: Ugel, Stefano, et al.
Publicado: (2023)

Invasion characteristics and clinical significance of tumor-associated macrophages in gastrointestinal Krukenberg tumors
por: Huang, Zigao, et al.
Publicado: (2023)

Gastrointestinal Goblet Cell Adenocarcinomas Harbor Distinctive Clinicopathological, Immune, and Genomic Landscape
por: Lin, Dong-Liang, et al.
Publicado: (2021)

Editorial: Intraoperative radiotherapy for gastrointestinal malignancy: updated evidence
por: Masaki, Tadahiko, et al.
Publicado: (2023)

Adjunctive Use of Circulating Tumor DNA Testing in Detecting Pancreas Cancer Recurrence
por: Soyano, Aixa E., et al.
Publicado: (2019)

Potential Applications of Circulating Tumor DNA Technology as a Cancer Diagnostic Tool
por: Kunnath, Anil P, et al.
Publicado: (2019)

Evaluation of circulating tumor DNA as a prognostic biomarker for metastatic pancreatic adenocarcinoma
por: Guan, Shasha, et al.
Publicado: (2022)

Clinical applications of circulating tumor cells in hepatocellular carcinoma
por: Hua, Yinggang, et al.
Publicado: (2022)

A clinical prognostic model for patients with esophageal squamous cell carcinoma based on circulating tumor DNA mutation features
por: Liu, Tao, et al.
Publicado: (2023)

Circulating Tumor DNA and Minimal Residual Disease (MRD) in Solid Tumors: Current Horizons and Future Perspectives
por: Peng, Yan, et al.
Publicado: (2021)

Tumor-informed or tumor-agnostic circulating tumor DNA as a biomarker for risk of recurrence in resected colorectal cancer patients
por: Chan, Hiu Ting, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fqbmpghvvtp8s401sttpitdi76